Who
Steve Miller
Chief Op. & Scientific Officer
Company insider
Files Form 4 as: Chief Op. & Scientific Officer, Catalyst Pharmaceutical.
In numbers
- Trades disclosed
- 136
- Buys
- 3
- Sells
- 10
- Bought
- $253K
- Sold
- $13.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Jan 2008
- Last trade
- 15 Jul 2026
- Last filed
- 17 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jul 2026filed 17 Jul 2026 | Catalyst PharmaceuticalBiotechnology | SEC FORM 4 Code D | $34.5M1,093,803 at $31.50 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticaloption or derivative · Biotechnology | SEC FORM 4 Code D | —16,534 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticaloption or derivative · Biotechnology | SEC FORM 4 Code D | —47,826 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticaloption or derivative · Biotechnology | SEC FORM 4 Code D | —180,000 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticaloption or derivative · Biotechnology | SEC FORM 4 Code D | —275,000 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —180,000 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —275,000 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —185,000 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —146,000 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —248,004 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —202,958 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —158,454 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —11,873 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —16,534 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —47,826 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticaloption or derivative · Biotechnology | SEC FORM 4 Code D | —185,000 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticaloption or derivative · Biotechnology | SEC FORM 4 Code D | —146,000 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticaloption or derivative · Biotechnology | SEC FORM 4 Code D | —248,004 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticaloption or derivative · Biotechnology | SEC FORM 4 Code D | —202,958 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticaloption or derivative · Biotechnology | SEC FORM 4 Code D | —158,454 at $0.00 | filing |
News
Ladle Names Steve Miller EVP, Grocery Pricing Operationsprnewswire.com · 1 Oct 2026
1 headline in the last 90 days name Steve Miller; no company of theirs resolves to a name we track.